Study record

MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

Reynolds JC, Lai RW, Woodhead JST et al. · Nat Commun · 2021

AnimalSeveralEvidence tier CAlso: Human observationalAlso: Cell study (in vitro)

What this study reported

Reported that administered MOTS-c increased physical performance in young, middle-aged and old mice, and that treatment begun in late life increased physical capacity and healthspan measures in mice. In humans, exercise was associated with higher endogenous MOTS-c expression in skeletal muscle and in circulation.

Limitations

Animal work used a single mouse strain with limited sex reporting, the human component is a small observational measurement rather than an intervention with MOTS-c, and healthspan outcomes are composite functional surrogates.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Speciesmouse, human
System studiedYoung, middle-aged and old mice given MOTS-c, mouse myoblasts, and skeletal muscle and circulation from exercising humans
PopulationNot reported
DesignControlled animal experiment with supporting cell and human exercise measurements
Sample size as reportedNot reported
Control groupuntreated age-matched mice
Route (data field only)Not reported
Endpoints measuredphysical performance; healthspan measures; nuclear gene expression; skeletal muscle metabolism; circulating and muscle MOTS-c
Pathways measuredNuclear translocation · AMPK signalling · SIRT1 / PGC-1α / biogenesis
Research areasAging · Exercise · Skeletal muscle · Mitochondrial biology
Evidence tierC — Animal in vivo
Publication typesJournal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Mammalian
Sample size
Not reported
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.